Our data presented here demonstrate that ZHX2 inhibits MDR1 expression, which promotes the intracellular accumulation of chemotherapeutic drugs and increases their cytotoxic effects in HCC. The gene discussed is ZHX2; the disease is hepatocellular carcinoma.